John Devine
Urology · Manhattan, KSNPI 1376533075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $569 and has fallen 97.4% since, to $15 in 2023. That places this record below the midpoint for urology clinicians in KS, where the typical reported total is $2,717.
Across 123 payments — averaging $14.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$415
- AbbVie$224
- Pfizer$178
- Johnson & Johnson$173
- Boston Scientific$156
- Travere Therapeutics, Inc.$104
- plus $520 from 17 others
What the payments were for
- Food & beverage$1,760100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 36 | $415 |
| AbbVie(2 entities) | 16 | $224 |
| Pfizer | 15 | $178 |
| Johnson & Johnson | 10 | $173 |
| Boston Scientific | 9 | $156 |
| Travere Therapeutics, Inc. | 5 | $104 |
| Urovant Sciences Inc | 4 | $66 |
| Blue Earth Diagnostics | 4 | $57 |
| Neotract Inc. | 3 | $50 |
| Antares Pharma, Inc. | 3 | $39 |
| Dendreon Pharmaceuticals LLC | 2 | $37 |
| 180 Medical, Inc. | 1 | $34 |
| Endo Pharmaceuticals Inc. | 2 | $33 |
| Coloplast | 2 | $31 |
| Tolmar Pharmaceuticals, Inc. | 2 | $31 |
| Myriad Genetic Laboratories, Inc. | 2 | $29 |
| Merck | 1 | $22 |
| Bard Access Systems, Inc. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Cook Medical LLC | 1 | $16 |
| Rochester Medical Corporation | 1 | $16 |
| Teleflex LLC | 1 | $13 |
| Olympus America Inc. | 1 | $12 |
How this compares
$1,769 in reported general payments places this provider in the 40th percentile of 111 urology providers in Kansas.
Other urology in Manhattan
- Felipe RossoManhattan$17K
- Kimberly KocourManhattan$7K
- Apostolos EvangelidisManhattan$4K
- Timothy RichardsonWichita$493K
- Wilson MolinaKansas City$239K
- Bristol WhilesKansas City$163K
- Jeffrey HolzbeierleinKansas City$78K
- Ahmad El-ArabiKansas City$55K
- David DucheneKansas City$33K
- Jason AnastOverland Park$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.